The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
dc.authorid | benekli, mustafa/0000-0003-3184-4946 | |
dc.authorid | Elkıran, Emin Tamer/0000-0001-6681-7249 | |
dc.authorid | Ozturk, Banu/0000-0003-0290-8787 | |
dc.authorwosid | benekli, mustafa/AAE-4555-2020 | |
dc.authorwosid | Elkıran, Emin Tamer/ABI-8192-2020 | |
dc.authorwosid | Gumus, Mahmut/C-7135-2008 | |
dc.authorwosid | Gumus, Mahmut/HTO-4176-2023 | |
dc.authorwosid | unal, olcun umit/IST-6684-2023 | |
dc.authorwosid | Ozturk, Banu/AAD-4358-2019 | |
dc.contributor.author | Yildiz, Ramazan | |
dc.contributor.author | Buyukberber, Suleyman | |
dc.contributor.author | Koca, Dogan | |
dc.contributor.author | Korai, Lokman | |
dc.contributor.author | Ciltas, Aydin | |
dc.contributor.author | Unal, Olcun Umit | |
dc.contributor.author | Gumus, Mahmut | |
dc.date.accessioned | 2024-08-04T21:02:03Z | |
dc.date.available | 2024-08-04T21:02:03Z | |
dc.date.issued | 2013 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/104431 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000335419603655 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience. | en_US |
dc.type | Conference Object | en_US |